The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats

International Journal of Neuropsychopharmacology

Volumn 12, Issue 3, 2009, Pages 329-341

  Conboy, Lisa ^a   Tanrikut, Cihan ^a   Zoladz, Phillip R ^b,c   Campbell, Adam M ^c   Park, Collin R ^b,c   Gabriel, Cecilia ^d   Mocaer, Elisabeth ^d   Sandi, Carmen ^a   Diamond, David M ^b,c  

^a EPFL   (Switzerland)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Antidepressant; Cell adhesion molecules; Hippocampus; Memory; Stress

Indexed keywords

AGOMELATINE; CORTICOSTERONE; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE 140; NERVE CELL ADHESION MOLECULE 180; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; ANTIDEPRESSANT AGENT; NERVE CELL ADHESION MOLECULE L1; POLYSIALYL NEURAL CELL ADHESION MOLECULE; SIALIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PREDATOR STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; DEPTH PERCEPTION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; LEARNING DISORDER; MENTAL STRESS; METABOLISM; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACETAMIDES; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LEARNING DISORDERS; MEMORY DISORDERS; NEURAL CELL ADHESION MOLECULE L1; RATS; RATS, SPRAGUE-DAWLEY; SIALIC ACIDS; SPACE PERCEPTION; STRESS, PSYCHOLOGICAL;

EID: 66449119956     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009255     Document Type: Article

References (85)

1. Akirav I, Kozenicky M, Tal D, Sandi C, Venero C, Richter-Levin G (2004). A facilitative role for corticosterone in the acquisition of a spatial task under moderate stress. Learning & Memory 11, 188-195.
2. Alfonso J, Frick LR, Silberman DM, Palumbo ML, Genaro AM, Frasch AC (2006). Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biological Psychiatry 59, 244-251.
3. Armitage R (2007). Sleep and circadian rhythms in mood disorders. Acta Psychiatrica Scandinavica (Suppl.), 433, 104-115. (Pubitemid 46114845)
4. Armstrong SM, McNulty OM, Guardiola-Lemaitre B, Redman JR (1993). Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS). Pharmacology, Biochemistry, and Behavior 46, 45-49.
5. Banasr M, Soumier A, Hery M, Mocaer E, Daszuta A (2006). Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biological Psychiatry 59, 1087-1096.
6. Bannerman DM, Good MA, Butcher SP, Ramsay M, Morris RG (1995). Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378, 182-186.
7. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T, Zhang WN, Pothuizen HH, Feldon J (2004). Regional dissociations within the hippocampus - memory and anxiety. Neuroscience and Biobehavioral Reviews 28, 273-283.
8. Barden N, Shink E, Labbe M, Vacher R, Rochford J, Mocaer E (2005). Antidepressant action of agomelatine (S 20098) in a transgenic mouse model. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29, 908-916.
9. Baydas G, Nedzvetsky VS, Nerush PA, Kirichenko SV, Demchenko HM, Reiter RJ (2002). A novel role for melatonin: regulation of the expression of cell adhesion molecules in the rat hippocampus and cortex. Neuroscience Letters 326, 109-112. (Pubitemid 34607571)
10. Baydas G, Ozer M, Yasar A, Tuzcu M, Koz ST (2005). Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats. Brain Research 1046, 187-194. (Pubitemid 40775889)
11. Bertaina-Anglade V, la Rochelle CD, Boyer PA, Mocaer E (2006). Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. Behavioural Pharmacology 17, 703-713.
12. Bonfanti L (2006). PSA-NCAM in mammalian structural plasticity and neurogenesis. Progress in Neurobiology 80, 129-164.
13. Bourin M, Mocaer E, Porsolt R (2004). Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. Journal of Psychiatry Neuroscience 29, 126-133.
14. Bouzioukh F, Tell F, Jean A, Rougon G (2001). NMDA receptor and nitric oxide synthase activation regulate polysialylated neural cell adhesion molecule expression in adult brainstem synapses. Journal of Neuroscience 21, 4721-4730. (Pubitemid 32565630)
15. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS (2000). Hippocampal volume reduction in major depression. American Journal of Psychiatry 157, 115-118.
16. Bremner JD, Vermetten E (2001). Stress and development: behavioral and biological consequences. Development and Psychopathology 13, 473-489.
17. Campbell AM, Park CR, Zoladz PR, Munoz C, Fleshner M, Diamond DM (2008). Pre-training administration of tianeptine, but not propranolol, protects hippocampus-dependent memory from being impaired by predator stress. European Neuropsychopharmacology 18, 87-98.
18. Chagraoui A, Protais P, Filloux T, Mocaer E (2003). Agomelatine (S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. Psychopharmacology 170, 17-22.
19. de Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C (2000). Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nature Neuroscience 3, 313-314.
20. Diamond DM, Park CR, Heman KL, Rose GM (1999). Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus 9, 542-552.
21. Diamond DM, Campbell A, Park CR, Vouimba RM (2004). Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. European Neuropsychopharmacology 14 (Suppl. 5), S491-495.
22. Diamond DM, Campbell AM, Park CR, Woodson JC, Conrad CD, Bachstetter AD, Mervis RF (2006). Influence of predator stress on the consolidation versus retrieval of long-term spatial memory and hippocampal spinogenesis. Hippocampus
23. Donohue HS, Gabbott PL, Davies HA, Rodriguez JJ, Cordero MI, Sandi C, Medvedev NI, Popov VI, Colyer FM, Peddie CJ, Stewart MG (2006). Chronic restraint stress induces changes in synapse morphology in stratum lacunosum-moleculare CA1 rat hippocampus: a stereological and three-dimensional ultrastructural study. Neuroscience 140, 597-606.
24. Ferbinteanu J, Ray C, McDonald RJ (2003). Both dorsal and ventral hippocampus contribute to spatial learning in Long-Evans rats. Neuroscience Letters 345, 131-135.
25. Foley AG, Hartz BP, Gallagher HC, Ronn LC, Berezin V, Bock E, Regan CM (2000). A synthetic peptide ligand of neural cell adhesion molecule (NCAM) IgI domain prevents NCAM internalization and disrupts passive avoidance learning. Journal of Neurochemistry 74, 2607-2613.
26. Foley AG, Hirst WD, Gallagher HC, Barry C, Hagan JJ, Upton N, Walsh FS, Hunter AJ, Regan CM (2008). The selective 5-HT(6) receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats. Neuropharmacology 54, 1166-1174.
27. Goodwin FK, Wirz-Justice A, Wehr TA (1982). Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. Advances in Biochemical Psychopharmacology 32, 1-11.
28. Hallonquist JD, Goldberg MA, Brandes JS (1986). Affective disorders and circadian rhythms. Canadian Journal of Psychiatry 31, 259-272.
29. Hammond MS, Sims C, Parameshwaran K, Suppiramaniam V, Schachner M, Dityatev A (2006). Neural cell adhesion molecule-associated polysialic acid inhibits NR2B-containing N-methyl-D-aspartate receptors and prevents glutamate-induced cell death. Journal of Biological Chemistry 281, 34859-34869.
30. Healy D, Waterhouse JM (1995). The circadian system and the therapeutics of the affective disorders. Pharmacology & Therapeutics 65, 241-263.
31. Heim C, Nemeroff CB (1999). The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biological Psychiatry 46, 1509-1522.
32. Hitoshi S, Maruta N, Higashi M, Kumar A, Kato N, Ikenaka K (2007). Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. Journal of Neuroscience Research 85, 3574-3585.
33. Hoffman KB, Murray BA, Lynch G, Munirathinam S, Bahr BA (2001). Delayed and isoform-specific effect of NMDA exposure on neural cell adhesion molecules in hippocampus. Neuroscience Research 39, 167-173.
34. Kennedy SH, Emsley R (2006). Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. European Neuropsychopharmacology 16, 93-100.
35. Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996). Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sciences 58, 1475-1483.
36. Loo H, Hale A, D'Haenen H (2002). Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. International Clinical Psychopharmacology 17, 239-247.
37. Lopez-Fernandez MA, Montaron MF, Varea E, Rougon G, Venero C, Abrous DN, Sandi C (2007). Upregulation of polysialylated neural cell adhesion molecule in the dorsal hippocampus after contextual fear conditioning is involved in long-term memory formation. Journal of Neuroscience 27, 4552-4561.
38. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
39. Lynch MA, Voss KL (1991). Presynaptic changes in long-term potentiation: elevated synaptosomal calcium concentration and basal phosphoinositide turnover in dentate gyrus. Journal of Neurochemistry 56, 113-118.
40. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences USA 100, 1387-1392.
41. Martinet L, Guardiola-Lemaitre B, Mocaer E (1996). Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacology, Biochemistry, and Behavior 54, 713-718.
42. Mazure CM (1995). Does Stress Cause Psychiatric Illness? Washington, DC: American Psychiatric Press.
43. McClung CA (2007). Circadian genes, rhythms and the biology of mood disorders. Pharmacology & Therapeutics 114, 222-232.
44. McEwen BS, Olie JP (2005). Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Molecular Psychiatry 10, 525-537.
45. Merino JJ, Cordero MI, Sandi C (2000). Regulation of hippocampal cell adhesion molecules NCAM and L1 by contextual fear conditioning is dependent upon time and stressor intensity. European Journal of Neuroscience 12, 3283-3290.
46. Mesches MH, Fleshner M, Heman KL, Rose GM, Diamond DM (1999). Exposing rats to a predator blocks primed burst potentiation in the hippocampus in vitro. Journal of Neuroscience 19, RC18.
47. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D (2003). The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. Journal of Pharmacology and Experimental Therapeutics 306, 954-964.
48. Millan MJ, Brocco M, Gobert A, Dekeyne A (2005). Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology 177, 448-458.
49. Montgomery SA (2006). Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist. European Neuropsychopharmacology 16, S633-S638.
50. Morris RG (1989). Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. Journal of Neuroscience 9, 3040-3057.
51. Morris RG, Anderson E, Lynch GS, Baudry M (1986). Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776.
52. Moser E, Moser MB, Andersen P (1993). Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. Journal of Neuroscience 13, 3916-3925.
53. Moser MB, Moser EI, Forrest E, Andersen P, Morris RG (1995). Spatial learning with a minislab in the dorsal hippocampus. Proceedings of the National Academy of Sciences USA 92, 9697-9701.
54. Murphy KJ, O'Connell AW, Regan CM (1996). Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multitrial spatial training. Journal of Neurochemistry 67, 1268-1274.
55. Murphy KJ, Foley AG, O'Connell AW, Regan CM (2006). Chronic exposure of rats to cognition enhancing drugs produces a neuroplastic response identical to that obtained by complex environment rearing. Neuropsychopharmacology 31, 90-100.
56. 2C antagonistic properties, in major depressive disorder. International Journalof Neuropsychopharmacology 10, 661-673.
57. Papp M, Gruca P, Boyer PA, Mocaer E (2003). Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28, 694-703.
58. Papp M, Litwa E, Gruca P, Mocaer E (2006). Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behavioural Pharmacology 17, 9-18.
59. Park CR, Campbell AM, Woodson JC, Smith TP, Fleshner M, Diamond DM (2006). Permissive influence of stress in the expression of a U-shaped relationship between serum corticosterone levels and spatial memory errors in rats. Dose-Response 4, 55-74.
60. Park CR, Zoladz PR, Conrad CD, Fleshner M, Diamond DM (2008). Acute predator stress impairs the consolidation and retrieval of hippocampus-dependent memory in male and female rats. Learning & Memory 15, 271-280.
61. Pham K, Nacher J, Hof PR, McEwen BS (2003). Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. European Journal of Neuroscience 17, 879-886.
62. Quera Salva MA, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C (2007). Major depressive disorder, sleep EEG and agomelatine: an open-label study. International Journal of Neuropsychopharmacology 10, 691-696.
63. Redman JR, Guardiola-LemaitreB, Brown M, Delagrange P, Armstrong SM (1995). Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms. Psychopharmacology 118, 385-390.
64. Rocher C, Spedding M, Munoz C, Jay TM (2004). Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cerebral Cortex 14, 224-229.
65. Sairanen M, O'Leary OF, Knuuttila JE, Castren E (2007). Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 144, 368-374.
66. Sandi C, Loscertales M, Guaza C (1997). Experience-dependent facilitating Journal of Neuroscience 9, 637-642.
67. Sandi C, Merino JJ, Cordero MI, Touyarot K, Venero C (2001). Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, its polysialylation, and L1. Neuroscience 102, 329-339.
68. Sandi C, Davies HA, Cordero MI, Rodriguez JJ, Popov VI, Stewart MG (2003). Rapid reversal of stress induced loss of synapses in CA3 of rat hippocampus following water maze training. European Journal of Neuroscience 17, 2447-2456.
69. Sandi C (2004). Stress, cognitive impairment and cell adhesion molecules. Nature Reviews Neuroscience 5, 917-930.
70. Sandi C, Woodson JC, Haynes VF, Park CR, Touyarot K, Lopez-Fernandez MA, Venero C, Diamond DM (2005). Acute stress-induced impairment of spatial memory is associated with decreased expression of neural cell adhesion molecule in the hippocampus and prefrontal cortex. Biological Psychiatry 57, 856-864.
71. Shakesby AC, Anwyl R, Rowan MJ (2002). Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. Journal Neuroscience 22, 3638-3644.
72. Sheline YI, Gado MH, Kraemer HC (2003). Untreated depression and hippocampal volume loss. American Journal of Psychiatry 160, 1516-1518.
73. Stewart MG, Davies HA, Sandi C, Kraev IV, Rogachevsky VV, Peddie CJ, Rodriguez JJ, Cordero MI, Donohue HS, Gabbott PL, Popov VI (2005). Stress suppresses and learning induces plasticity in CA3 of rat hippocampus: a three-dimensional ultrastructural study of thorny excrescences and their postsynaptic densities. Neuroscience 131, 43-54.
74. Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G (2004). Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry 56, 640-650. (Pubitemid 39446845)
75. Touyarot K, Sandi C (2002). Chronic restraint stress induces an isoform-specific regulation on the neural cell adhesion molecule in the hippocampus. Neural Plasticity 9, 147-159.
76. Tsuang MT (2000). Genes, environment, and mental health wellness. American Journal of Psychiatry 157, 489-491.
77. Van Reeth O, Olivares E, Zhang Y, Zee PC, Mocaer E, Defrance R, Turek FW (1997). Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters. Brain Research 762, 185-194.
78. Varea E, Blasco-Ibanez JM, Gomez-Climent MA, Castillo-Gomez E, Crespo C, Martinez-Guijarro FJ, Nacher J (2007a). Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex. Neuropsychopharmacology 32, 803-812.
79. Varea E, Castillo-Gomez E, Gomez-Climent MA, Blasco-Ibanez JM, Crespo C, Martinez-Guijarro FJ, Nacher J (2007b). Chronic antidepressant treatment induces contrasting patterns of synaptophysin and PSA-NCAM expression in different regions of the adult rat telencephalon. European Neuropsychopharmacology 17, 546-557.
80. Venero C, Herrero AI, Touyarot K, Cambon K, Lopez-Fernandez MA, Berezin V, Bock E, Sandi C (2006). Hippocampal up-regulation of NCAM expression and polysialylation plays a key role on spatial memory. European Journal of Neuroscience 23, 1585-1595.
81. Vouimba RM, Munoz C, Diamond DM (2006). Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 9, 29-40.
82. Woodson JC, Macintosh D, Fleshner M, Diamond DM (2003). Emotion-induced amnesia in rats: working memory-specific impairment, corticosterone-memory correlation, and fear versus arousal effects on memory. Learning & Memory 10, 326-336.
83. Ying SW, Rusak B, Delagrange P, Mocaer E, Renard P, Guardiola-Lemaitre B (1996). Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. European Journal of Pharmacology 296, 33-42.
84. Yous S, Andrieux J, Howell HE, Morgan PJ, Renard P, Pfeiffer B, Lesieur D, Guardiola-Lemaitre B (1992). Novel naphthalenic ligands with high affinity for the melatonin receptor. Journal of Medicinal Chemistry 35, 1484-1486.
85. Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM (2006). Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacology, Biochemistry, and Behavior 85, 298-306.